↓ Skip to main content

Hesperidin Inhibits Lung Cancer In Vitro and In Vivo Through PinX1

Overview of attention for article published in Frontiers in Pharmacology, July 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Hesperidin Inhibits Lung Cancer In Vitro and In Vivo Through PinX1
Published in
Frontiers in Pharmacology, July 2022
DOI 10.3389/fphar.2022.918665
Pubmed ID
Authors

Yang Yao, Mingyue Lin, Zhujun Liu, Mengyang Liu, Shiheng Zhang, Yukun Zhang

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 4 18%
Unspecified 2 9%
Student > Bachelor 2 9%
Professor 1 5%
Student > Master 1 5%
Other 1 5%
Unknown 11 50%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 14%
Unspecified 2 9%
Biochemistry, Genetics and Molecular Biology 2 9%
Agricultural and Biological Sciences 1 5%
Medicine and Dentistry 1 5%
Other 2 9%
Unknown 11 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2023.
All research outputs
#14,711,219
of 23,565,002 outputs
Outputs from Frontiers in Pharmacology
#4,972
of 17,155 outputs
Outputs of similar age
#208,605
of 438,805 outputs
Outputs of similar age from Frontiers in Pharmacology
#268
of 1,236 outputs
Altmetric has tracked 23,565,002 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,155 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,805 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,236 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.